Jinju Biomedicine Overview
- Year Founded
-
2024
- Status
-
Private
- Latest Deal Type
-
Series A
- Investors
-
2
Jinju Biomedicine General Information
Description
Manufacturer of a cell-therapy biopharmaceutical products company intended to develop stem-cell spheroid therapies. The company offers a stem cell sphere treatment, injectable stem-cell products, and multiple therapeutic-area coverage (joints, heart, anti-aging, etc.), enabling clinical and medical-cosmetic developers to access advanced regenerative therapies.
Contact Information
Corporate Office
- Number 699-18 Xuanwu Avenue
- Xuanwu District
- Nanjing, 210000
- China
Corporate Office
- Number 699-18 Xuanwu Avenue
- Xuanwu District
- Nanjing, 210000
- China
Jinju Biomedicine Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC (Series A) | 19-Nov-2025 | Completed | Generating Revenue |
Jinju Biomedicine Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Sinopharm Group | Corporation | Minority | ||
| Tenyall Investment | Venture Capital | Minority |
Jinju Biomedicine FAQs
-
When was Jinju Biomedicine founded?
Jinju Biomedicine was founded in 2024.
-
Where is Jinju Biomedicine headquartered?
Jinju Biomedicine is headquartered in Nanjing, China.
-
What industry is Jinju Biomedicine in?
Jinju Biomedicine’s primary industry is Biotechnology.
-
Is Jinju Biomedicine a private or public company?
Jinju Biomedicine is a Private company.
-
What is Jinju Biomedicine’s current revenue?
The current revenue for Jinju Biomedicine is .
-
Who are Jinju Biomedicine’s investors?
Sinopharm Group and Tenyall Investment have invested in Jinju Biomedicine.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process